“In determining whether a net cash amount of $12 million has been raised, the Company may also treat any expected proceeds on completion from any unconditional sale and purchase agreement that has been entered into for the sale of the Infusion business before the close of the Entitlement Offer as contributing to determining whether a net cash amount of $12 million has been raised.“
Does that mean if we sell infusions we may not have to raise all the funds and not get diluted as much?
- Forums
- ASX - By Stock
- AVR
- Rights Issue
Rights Issue, page-15
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.75 |
Change
-0.110(1.01%) |
Mkt cap ! $227.2M |
Open | High | Low | Value | Volume |
$10.95 | $10.95 | $10.24 | $285.2K | 26.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $10.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.75 | 413 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 10.490 |
2 | 1097 | 10.300 |
4 | 4003 | 10.200 |
1 | 500 | 10.150 |
2 | 1450 | 10.100 |
Price($) | Vol. | No. |
---|---|---|
10.750 | 413 | 1 |
10.950 | 4 | 1 |
11.000 | 3758 | 1 |
11.800 | 200 | 1 |
12.000 | 5000 | 1 |
Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
Harsh Shethia, Advisor
Harsh Shethia
Advisor
SPONSORED BY The Market Online